Company / Current Liabilities per Share
NeoGenomics Laboratories, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.69
FY2025
5-year range
$0.69 / $2.38
FY2021-FY2025
Trend
-71.0%
vs FY2024
Sector context
#143 of 158
Health Care
What the data says
Among 158 Health Care companies, NeoGenomics Laboratories, Inc. is in the top 9% for current liabilities per share. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.46 in FY2017 to $2.38 in FY2024.
Based on SEC 10-K filings.
0.69 in FY2025 with a 5-year CAGR of +1.0%.
Improved from $0.77 to $0.69 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -1.6%
- 5-Year CAGR
- +1.0%
- 10-Year CAGR
- -
Sector benchmark
-97.7% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 71.0% year-over-year.
- Ranks #143 out of 158 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2024.
- Lowest current liabilities per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.69 | -71.0% |
| FY2024 | $2.38 | +209.9% |
| FY2023 | $0.77 | +6.0% |
| FY2022 | $0.72 | -0.4% |
| FY2021 | $0.73 | +11.1% |
| FY2020 | $0.65 | +6.1% |
| FY2019 | $0.62 | -7.3% |
| FY2018 | $0.67 | +43.3% |
| FY2017 | $0.46 | -7.7% |
| FY2016 | $0.50 | -24.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026